ANAL SQUAMOUS CELL CARCINOMA
Clinical trials for ANAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Daily-Tailored radiation may spare healthy tissue in anal cancer
Disease control Recruiting nowThis pilot study tests whether daily-adjusted radiation therapy can better target anal cancer while reducing harm to nearby organs. About 20 adults with locally advanced anal cancer will receive radiation plans that adapt to daily changes in their anatomy. The goal is to see if t…
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated May 17, 2026 00:44 UTC
-
New hope for tough cancers: EVOLVE104 trial begins
Disease control Recruiting nowThis early-phase study tests a new drug called EVOLVE104 in people with advanced bladder cancer or several types of squamous cell cancers (lung, esophagus, skin, and others) that have not responded to standard treatments. About 160 participants will receive the drug to see if it …
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
MRI-Guided radiation tailored to risk could transform anal cancer treatment
Disease control Recruiting nowThis study tests a new way to give radiation therapy for anal cancer using real-time MRI guidance. The radiation dose is adjusted based on each patient's risk level (low, standard, intermediate, or high). About 80 adults with anal squamous cell carcinoma will take part. The goal …
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 07, 2026 18:42 UTC